The nanoparticulate carrier systems as solid lipid nanoparticles (SLNs) and nanostructured
lipid carriers (NLCs) have gained interest for the topical treatment of skin associated fungal …

Background: The present work focuses on the development of ultra-small solid lipid
nanoparticles (SLN) and nanostructured lipid carriers (NLC) encapsulating cyclosporine and …

Fucoxanthin (FUCO), a marine carotenoid is photo-, and thermo-labile and poorly
bioavailable due to its lipophilicity. Hence, we developed a chitosan (CS)+ glycolipid (GL) …

The aim of this work was the preparation of solid lipid nanoparticles, based on trehalose
monooleate, loaded with cyclosporin-A for potential treatment of psoriasis. Trehalose was …

Psoriasis is chronic autoimmune disease that affects 2–5% of the global population.
Fluocinolone acetonide (FLU) and acitretin (ACT) are widely used antipsoriatic drugs that …

Skin aging might happen due to extrinsic and intrinsic factors that usually can induce the
increase of free radicals and generate oxidative stress, which lead to skin alterations. Thus …

The aim of this study was to develop, optimize and evaluate the potential of solid lipid
nanoparticles (SLNs) as a topical delivery system for targeted and prolonged release of …

Background: Curcumin (CUR) is a well-known herbal constituent used in treating psoriasis.
However, combination of CUR with other anti-inflammatory drugs such as caffeine shows …

Cyclosporine A (CsA) is an immunosuppressant frequently used in the therapy of
autoimmune disorders, including skin-related diseases. Aiming towards topical delivery …

This investigation is a study of new lipid nanoparticles for cutaneous antioxidant delivery.
Several molecules, such as α-tocopherol and retinoic acid, have been shown to improve …